Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25484121 | 0.90 | HTR2A (0.30) | HTR2A | |
| SCHEMBL14825824 | 0.79 | HTR2A (0.36) | HTR2A | |
| SCHEMBL23870800 | 0.67 | KDM1A (0.41) | HTR2AKDM1A | |
| SCHEMBL13677450 | 0.67 | HTR2A (0.33) | HTR2A | |
| SCHEMBL15354053 | 0.65 | ALDH1A1 (0.52) | HTR2A | |
| SCHEMBL5229247 | 0.64 | ALDH1A1 (0.35) | HTR2AKDM1A | |
| SCHEMBL19780929 | 0.63 | HTR2A (0.31) | HTR2A | |
| SCHEMBL15428029 | 0.62 | HSP90AA1 (0.35) | HTR2AKDM1A | |
| SCHEMBL26027090 | 0.58 | — | — | |
| SCHEMBL25130127 | 0.58 | KDM1A (0.38) | HTR2AKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183269-A1 | POLYCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2023-06-15 | — | — | US | disclosed |
| US-20230183269-A1 | POLYCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183269-A1 | POLYCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | VDAC2, VDAC3, KCNC1 | HTR2A 3768/4885KDM1A 3096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.